Intellectual Property India Publishes Patent Application for 'Methods For Treating Obesity With An Mc4r Agonist' Filed by Rhythm Pharmaceuticals, Inc.

MUMBAI, India, Aug. 8 -- Intellectual Property India has published a patent application (202517011784 A) filed by Rhythm Pharmaceuticals, Inc., Boston, on Feb. 12, for 'methods for treating obesity with an mc4r agonist.'

Inventor(s) include Shah, Bhavik, P.; Kleyn, Patrick, Willem; Scimia, Maria, Cecilia; and Meeker, David, Pell.

The application for the patent was published on Aug. 8, under issue no. 32/2025.

According to the abstract released by the Intellectual Property India: "The disclosure is related to a method of treating a non-genetic obesity (e.g., hypothalamic obesity) in a subject using a melanocortin-4 receptor (MC4R) agonist."

The patent application was internationally filed on July 12, 2023, under International application No.PCT/US2023/070084.

Disclaimer: Curated by HT Syndication.